Evidence map›Paper›PMID 35207139›Full record

ArticleMembranes2022

A Novel Application of Recycled Ultrafiltration Membranes in an Aerobic Membrane Bioreactor (aMBR): A Proof-of-Concept Study.

Laura Rodríguez-Sáez, Sotiris I Patsios, Jorge Senán-Salinas, Junkal Landaburu-Aguirre, Serena Molina, Eloy García-Calvo

Abstract read
In one paragraph

Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura Rodríguez-SáezIMDEA Water Institute, Av. Punto Com, 2, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0001-8502-6389
Sotiris I PatsiosLaboratory of Natural Resources and Renewable Energies, Chemical Process & Energy Resources Institute (CPERI), Centre for Research and Technology-Hellas (CERTH), GR Thermi, 57001 Thessaloniki, Greece.ORCID 0000-0002-7180-9291
Jorge Senán-SalinasIMDEA Water Institute, Av. Punto Com, 2, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0001-8127-5425
Junkal Landaburu-AguirreIMDEA Water Institute, Av. Punto Com, 2, Alcalá de Henares, 28805 Madrid, Spain.
Serena MolinaIMDEA Water Institute, Av. Punto Com, 2, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0002-7316-0019
Eloy García-CalvoIMDEA Water Institute, Av. Punto Com, 2, Alcalá de Henares, 28805 Madrid, Spain.

Funding

European Regional Development Fund-INREMEM CTM2015-65348-C2-1-REuropean Regional Development Fund-INREMEM 2 RTI2018-096042-B-C21Ministry of Science and Innovation-INREMEM CTM2015-65348-C2-1-RMinistry of Science and Innovation-INREMEM 2 RTI2018-096042-B-C21Ministry of Science and Innovation-nanoCLEAN PID2019-111519RA-I00State Research Agency-INREMEM CTM2015-65348-C2-1-RState Research Agency-INREMEM 2 RTI2018-096042-B-C21State Research Agency-nanoCLEAN PID2019-111519RA-I00
6 · The paper itself

Abstract

The use of recycled ultrafiltration (r-UF) membranes, originating from end-of-life reverse osmosis membranes, as submerged flat-sheet membranes in an aerobic membrane bioreactor (aMBR) system is described herein for the first time. A feasibility study of this new approach was performed in a laboratory-scale aMBR system. The r-UF membrane performance was evaluated in terms of permeability, fouling behavior, and permeate quality using a widely used commercial flat sheet microfiltration membrane (c-MF) as a reference. Tests were conducted under steady-flux operation (at 12 and 14 L·m

Indexed as

circular economycost analysismembrane bioreactor (MBR)recycled ultrafiltration membranerecycling

Identifiers

PMID35207139
PMCPMC8878474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.